Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
The overall goal of this imaging trial is to evaluate [18F]MNI-952 (also known as [18F]UCB-K), a tau targeted PET radioligand.
100 项与 18F-MNI-952 相关的临床结果
100 项与 18F-MNI-952 相关的转化医学
100 项与 18F-MNI-952 相关的专利(医药)
100 项与 18F-MNI-952 相关的药物交易